CSX vs ORGO · P/E 19, rev $7.42B vs rev $81.0M
CSX Corporation (CSX) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the CSX and ORGO stock pages for the full models.
Not investment advice.